JAC Advance Access originally published online on December 16, 2005
Journal of Antimicrobial Chemotherapy 2006 57(2):353-355; doi:10.1093/jac/dki456
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model
1 Laboratoire de Parasitologie, ADEN EA3234, CHU Charles Nicolle, 76031 Rouen, France; 2 College of Pharmacy, Xinjiang Medical University, Urumqi, China; 3 Laboratoire d'Immunologie, EA 2128, CHU Clemenceau, 14033 Caen, France; 4 Service d'Anatomie Pathologique, CHU Charles Nicolle, 76031 Rouen, France; 5 Romark Institute for Medical Research, Tampa, FL 33607, USA
Received 21 March 2005; revised 30 September 2005; accepted 16 November 2005
* Corresponding author. Tel: +33-2-32-88-66-39; Fax: +33-2-32-88-68-75; E-mail: loic.favennec{at}chu-rouen.fr
Objectives: To evaluate the efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed Mongolian gerbil (Meriones unguiculatus) model.
Methods: Gerbils (1-month-old) were dexamethasone-immunosuppressed for 10 days and challenged orally with 105 Cryptosporidium parvum oocysts. From day 0 to day 12 post-infection, one group (n = 14) was treated with 200 mg/kg/day nitazoxanide and another (n = 15) with 100 mg/kg/day paromomycin. Infection and efficacy of nitazoxanide and paromomycin were assessed by measuring oocyst shedding in faeces, biliary tract and ileum histological examination.
Results: In nitazoxanide-treated and paromomycin-treated groups as compared with untreated animals (P < 0.05), oocyst shedding was partially suppressed in a similar manner (P > 0.05). Parasites were present in histological sections of the ileal mucosa of 16/16 infected untreated animals versus 3/14 and 6/15 in the nitazoxanide-treated and the paromomycin-treated groups, respectively (P < 0.05). In addition, gall bladder infection was less frequent in nitazoxanide-treated (2/14, P < 0.01) and paromomycin-treated (5/15, P = 0.07) animals than in untreated controls (9/16). No histological alteration of biliary mucosa was observed in both treated and untreated infected gerbils.
Conclusions: Present data support the efficacy of nitazoxanide and, to a lesser extent, paromomycin on biliary C. parvum infection in gerbils, and prompt further investigation of the potential clinical benefits of nitazoxanide in treating human biliary cryptosporidiosis.
Keywords: Cryptosporidium parvum , Meriones unguiculatus , gall bladders , cryptosporidial cholangitis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Khaldi, G. Gargala, L. Le Goff, S. Parey, A. Francois, J. Fioramonti, J.-J. Ballet, J.-P. Dupont, P. Ducrotte, and L. Favennec Cryptosporidium parvum Isolate-Dependent Postinfectious Jejunal Hypersensitivity and Mast Cell Accumulation in an Immunocompetent Rat Model Infect. Immun., November 1, 2009; 77(11): 5163 - 5169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Jex, A. Pangasa, B. E. Campbell, M. Whipp, G. Hogg, M. I. Sinclair, M. Stevens, and R. B. Gasser Classification of Cryptosporidium Species from Patients with Sporadic Cryptosporidiosis by Use of Sequence-Based Multilocus Analysis following Mutation Scanning J. Clin. Microbiol., July 1, 2008; 46(7): 2252 - 2262. [Abstract] [Full Text] [PDF]
|
|